Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 9, 2005, Pages 5247-5253

  Kemp, Stephen F ^a   Kuntze, Joyce ^b   Attie, Kenneth M ^b   Maneatis, Thomas ^c   Butler, S ^c   Frane, James ^b   Lippe, Barbara ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Genentech Inc ^*

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATREM;

AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; CATCH UP GROWTH; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GROWTH RATE; HORMONAL THERAPY; HUMAN; IDIOPATHIC DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; PRIORITY JOURNAL; SEIZURE; SEX DIFFERENCE; SHORT STATURE; TREATMENT OUTCOME;

EID: 24344452449     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2004-2513     Document Type: Article

References (23)

1. Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radclinffe FJ, Cuttler L 2002 Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Arch Pediatr Adolesc Med 156:230-240
2. Attie K, Frane J 2004 Idiopathic short stature and growth hormone: prognosis for height with and without treatment. Growth Hormone IGF Res 14:139
3. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler GB, Baron J 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148
4. Hintz RL, Attie KM, Baptista J, Roche A, for the Genentech Collaborative Group 1999 Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med 340:502-507
5. August GP, Lippe BM, Blethen SL, Rosenfeld RG, Seelig SA, Johanson AJ, Comptom PG, Frane JW, McClellan BH, Sherman BM 1990 Growth hormone treatment in the United States: demographic features of 2331 children. J Pediatr 116:899-903
6. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL 2002 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11:1-190
7. Tanner JM 1986 Use and abuse of growth standards. In: Falkner F, Tanner JM, eds. Human growth. A comprehensive treatise. 2nd ed, vol 3. New York: Plenum Press; 95-109
8. Anderson RN 2002 Deaths: leading causes for 2000. National vital statistics reports. Vol 50. Hyattsville, MD: National Center for Health Statistics
9. 2003 SEER cancer statistics review, 1975-2000. Available from: http://seer.cancer.gov/csr/1975_2000
10. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD 2000 The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the United Kingdom. Brain 123:665-676
11. Center for Disease Control's diabetes surveillance report, 1995. Available from: http://diabetes.niddk.nih.gov/dm/pubs/amerca/contents.htm
12. Armitage P, Berry G 1994 Statistical methods in medical research. London: Blackwell Scientific Publication; 142-143
13. Root AW, Kemp SF, Rundle AC, Dana K, Attie KM 1998 Effect of long-term recombinant growth hormone therapy in children - the National Cooperative Growth Study, USA, 1985-1994. J Ped Endocrinol Metab 11:403-412
14. Wit JM, Kamp GA, Rikken B 1996 Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 39:295-302
15. Buchlis JG, Irizarry L, Crotzer BC, Shine BJ, Allen L, MacGillivray MH 1998 Comparison of final heights of growth hormone-treated vs. untreated children with idiopathic growth failure. J Clin Endocrinol Metab 83:1075-1079
16. Guyda HJ 1999 Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 84:4307-4316
17. Ranke MB, Grauer ML, Kistner K, Blum WF, Wollmann HA 1995 Spontaneous adult height in idiopathic short stature. Horm Res 44:152-157
18. Price DA 1996 Spontaneous adult height in patients with idiopathic short stature. Horm Res 45(Suppl 2):59-63
19. Rekers-Mombarg LTM, Wit JM, Massa GG, Ranke MB, Buckler JMH, Butenandt O, Chaussain JL, Frisch H, Leiberman E 1996 Spontaneous growth in idiopathic short stature. Arch Dis Child 75:175-180
20. Wit JM, Rekers-Mombarg LTM, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain J-L, Frisch H, Yturriaga R, Attanasio AF 2005 Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146:45-53
21. Blethen SL, Allen DB, Graves D, August A, Moshang T, Rosenfeld R 1996 Safety of recombinant deoxyribonucleic acid-derived growth hormone: the National Cooperative Growth Study Experience. J Clin Endocrinol Metab 81:1704-1710
22. Maneatis T, Baptista J, Connelly K, Blethen S 2000 Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 13:1035-1044
23. Allen DB, Fost N 2004 hGH for short stature: ethical issues raised by expanded access. J Pediatr 144:648-652